Teva Pharmaceuticals
TEVA
TEVA
558 hedge funds and large institutions have $10.9B invested in Teva Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 194 increasing their positions, 187 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
22% less first-time investments, than exits
New positions opened: 67 | Existing positions closed: 86
26% less capital invested
Capital invested by funds: $14.7B → $10.9B (-$3.75B)
28% less funds holding in top 10
Funds holding in top 10: 36 → 26 (-10)
Holders
558
Holding in Top 10
26
Calls
$515M
Puts
$369M
Top Buyers
| 1 | +$394M | |
| 2 | +$153M | |
| 3 | +$113M | |
| 4 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$112M |
| 5 |
DFO
Duquesne Family Office
New York
|
+$105M |
Top Sellers
| 1 | -$154M | |
| 2 | -$114M | |
| 3 | -$93.5M | |
| 4 |
MRCP
Maple Rock Capital Partners
Toronto,
Ontario, Canada
|
-$92.8M |
| 5 |
Morgan Stanley
New York
|
-$69.9M |